116 related articles for article (PubMed ID: 25634083)
1. Psoriasis vulgaris with or without arthritis and independent of disease severity or duration is a risk factor for hypercholesterolemia.
Santos-Juanes J; Coto-Segura P; Fernández-Vega I; Armesto S; Martínez-Camblor P
Dermatology; 2015; 230(2):170-6. PubMed ID: 25634083
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
3. Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA Study.
Guallar-Castillón P; Gil-Montero M; León-Muñoz LM; Graciani A; Bayán-Bravo A; Taboada JM; Banegas JR; Rodríguez-Artalejo F
Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):551-8. PubMed ID: 22483404
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
5. Meibomian gland dysfunction and hypercholesterolemia.
Pinna A; Blasetti F; Zinellu A; Carru C; Solinas G
Ophthalmology; 2013 Dec; 120(12):2385-2389. PubMed ID: 23747164
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia and its association with meibomian gland dysfunction.
Braich PS; Howard MK; Singh JS
Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
[TBL] [Abstract][Full Text] [Related]
7. Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad.
Bajaj DR; Mahesar SM; Devrajani BR; Iqbal MP
J Pak Med Assoc; 2009 Aug; 59(8):512-5. PubMed ID: 19757693
[TBL] [Abstract][Full Text] [Related]
8. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
9. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
10. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
11. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
13. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
Velussi M
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
[TBL] [Abstract][Full Text] [Related]
14. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
16. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
[TBL] [Abstract][Full Text] [Related]
17. Low total, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol levels in patients with complex congenital heart disease after Fontan palliation.
Whiteside W; Tan M; Yu S; Rocchini A
J Pediatr; 2013 Jun; 162(6):1199-204. PubMed ID: 23312682
[TBL] [Abstract][Full Text] [Related]
18. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
[TBL] [Abstract][Full Text] [Related]
19. [Study of the prevalence of hypercholesterolemia in Extremadura].
Gimeno Ortiz A; Jiménez Romano R; Vázquez Domínguez JA; Rueda Muñoz C
Rev Sanid Hig Publica (Madr); 1993; 67(4):267-78. PubMed ID: 7732293
[TBL] [Abstract][Full Text] [Related]
20. Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis.
Shrestha A; Bahce-Altuntas A; Mowrey W; Broder A
Semin Arthritis Rheum; 2016 Dec; 46(3):286-290. PubMed ID: 27373499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
